All terms
CommercializationHospital Buyer & Reimbursement
Physician Payments Sunshine Act
U.S. law requiring disclosure of payments to physicians and teaching hospitals.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
The Sunshine Act (Open Payments program) requires manufacturers of drugs, devices, biologics, and medical supplies covered by Medicare/Medicaid/CHIP to report transfers of value to physicians, certain non-physician practitioners, and teaching hospitals. What the regulation says
The Physician Payments Sunshine Act, also known as the Open Payments program, mandates that applicable manufacturers report payments and other transfers of value made to covered recipients to the Centers for Medicare & Medicaid Services (CMS), as detailed in 42 CFR Part 403, Subpart I. This regulation aims to increase transparency regarding financial relationships between the healthcare industry and healthcare providers, aligning with broader transparency initiatives from bodies like the FDA regarding medical device marketing practices.
What this means in practice
Reported annually by CMS and publicly searchable. Mis-reporting creates reputational and enforcement risk; KOL agreements must be FMV and well-documented.Examples
- A medical device company pays a surgeon a consulting fee for their expertise in developing a new surgical tool, requiring this payment to be reported to CMS.
- A pharmaceutical manufacturer sponsors a physician's travel and accommodation to attend an educational conference where their drug is discussed, necessitating disclosure under the Open Payments program.
- A MedTech company provides a research grant to a teaching hospital for a study involving their diagnostic equipment, which then must be reported to CMS.
Common pitfalls
- •Failing to accurately categorize transfers of value can lead to misreporting and penalties.
- •Inadequate documentation of fair market value for key opinion leader (KOL) agreements can result in non-compliance.
- •Overlooking indirect payments or transfers of value made through third parties can lead to enforcement actions.
- •Not understanding the specific definitions of "applicable manufacturer" and "covered recipient" can lead to reporting errors.
Frequently asked questions
Manufacturers must report a broad range of transfers of value, including consulting fees, research grants, meals, travel, educational items, and charitable contributions, if they exceed certain thresholds outlined by CMS.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsCommercialization
Advisory Board
Convening of external experts to advise on strategy or product.
Commercialization
Anti-Kickback Statute(AKS)
U.S. criminal statute prohibiting remuneration to induce federal healthcare business.
Commercialization
Key Opinion Leader(KOL)
Influential clinician who shapes peer practice and adoption.
More in Commercialization
· Same categoryCommercialization
AdvaMed Code of Ethics
Industry code governing interactions between U.S. medical-device companies and healthcare professionals.
Commercialization
Bottom-Up Market Sizing
Building market size from procedure volumes × price × penetration.
Commercialization
Distributor vs Direct Sales
Choice between selling through third-party distributors or hiring a direct salesforce.
Commercialization
Field Clinical Engineer(FCE)
Manufacturer representative providing clinical and technical support in the OR or cath lab.
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
CMS·1AdvaMed·1AHRMM·1
- 1
CMS Open PaymentsVerifiedCMScms.gov
- 2
AdvaMed Code of EthicsVerifiedAdvaMedadvamed.org
- 3
AHRMM - Healthcare Supply ChainVerifiedAHRMMahrmm.org
Inline markers like [1] jump to the matching reference above.